Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy.

Simple item page
dc.contributor.authorInstituto Global para la Excelencia en el Cuidado de la Salud Keralty
dc.date.accessioned2026-04-17T15:46:31Z
dc.date.available2026-04-17T15:46:31Z
dc.date.issued2021
dc.formattext
dc.identifier.urihttps://repositorio.unisanitas.edu.co/handle/123456789/1337
dc.language.isoen
dc.publisherKeralty
dc.relation.ispartofNefrología
dc.relation.urihttps://doi.org/10.1016/j.nefro.2021.10.001
dc.titleLow dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy.
dc.typePublicacion
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Informacion.txt
Size:
248 B
Format:
Plain Text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.15 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Publicaciones